National Institute on Drug Abuse (NIDA)

The 22nd Annual National Institute on Drug Abuse (NIDA) International Forum was held in Montreal, Canada from June 16th – 19th, 2017.

This misuse of prescription opioids is a major public health challenge. Buprenorphine-naloxone (bup-nx) is typically used to treat opioid use disorders. However, the drug’s clinical trial primarily involved heroin users. It was therefore...

The National Institute on Drug Abuse (NIDA) has released a number of new resources. These are aimed at those working within the criminal justice system and other environments where people in recovery from drug addiction are ready to return...

New research supported by the National Institute on Drug Abuse (NIDA) has found through a comparison of treatment approaches for opioid dependence that, in an emergency setting, combining the medication buprenorphine with on-going care is...

Contingency management (CM) is a widely used behavioural therapy for substance use disorders. It offers material rewards for attending sessions and adhering to prescribed medication courses, amongst other positive behaviours. A study...

Besides reducing substance use between its participants one prevention programme also reduced drug use among the friends of those who took part.

Heroin and synthetic opioids are propelling an upsurge of late in cocaine-related overdose deaths. This is according to a national survey carried out by researchers at the National Institute on Drug Abuse (NIDA) amongst other drug...

Are you a teacher? Are you looking for materials or lesson plans on the effects of drugs and drug abuse? The National Institute on Drug Abuse (NIDA) has created a great database of more than 70 teacher materials on the effects of drugs and...